SMTL ID : 3r8g.1

AKR1C3 complex with ibuprofen

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.80 Å

Oligo State

monomer

Ligands

1 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)

NAP.1: 30 residues within 4Å: Chain A: G.22, T.23, Y.24, D.50, Y.55, K.84, H.117, S.166, N.167, Q.190, Y.216, S.217, A.218, L.219, G.220, S.221, Q.222, L.236, A.253, L.268, A.269, K.270, S.271, Y.272, N.273, R.276, Q.279, N.280, F.306 Ligands: IZP.2 28 PLIP interactions: 28 interactions with chain A Hydrophobic interactions: A:F.306 Hydrogen bonds: A:T.23, A:Y.24, A:D.50, A:S.166, A:N.167, A:Q.190, A:S.217, A:L.219, A:G.220, A:S.221, A:Q.222, A:Q.222, A:Q.222, A:L.268, A:K.270, A:S.271, A:Y.272, A:Q.279, A:N.280 Water bridges: A:S.217, A:A.218, A:A.218, A:Q.279 Salt bridges: A:K.270, A:R.276 pi-Stacking: A:Y.216 pi-Cation interactions: A:R.276

1 x IZP: (2R)-2-[4-(2-methylpropyl)phenyl]propanoic acid(Non-covalent)

IZP.2: 11 residues within 4Å: Chain A: L.54, Y.55, H.117, M.120, N.167, Y.216, F.306, F.311, P.318, Y.319 Ligands: NAP.1 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:L.54, A:F.306, A:F.306, A:F.306, A:F.311, A:F.311, A:P.318, A:Y.319 Salt bridges: A:H.117 pi-Stacking: A:F.311

1 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.3: 9 residues within 4Å: Chain A: Q.6, P.17, V.18, L.19, G.45, F.46, R.47, H.48, F.284 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:Q.6, A:V.18, A:L.19, A:R.47, A:H.48

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Flanagan, J.U. et al., Crystal structures of three classes of non-steroidal anti-inflammatory drugs in complex with aldo-keto reductase 1C3. Plos One (2012)

Release Date

2012-05-02

Peptides

Aldo-keto reductase family 1 member C3: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Aldo-keto reductase family 1 member C3

Related Entries With Identical Sequence